Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals

Boston Medical Center (BMC) Office Based Addiction Treatment (OBAT) Training and Technical Assistance (TTA)

Expanding access to life-saving treatment for substance use disorders through education, support, and capacity building

Boston Medical Center's (BMC) Office Based Addiction Treatment (OBAT) Training and Technical Assistance (TTA) provides education, support and capacity building to community health centers and other health care and social service providers on best practices caring for patients with substance use disorders.

Upcoming events

Substance Use in Adolescents, Older Adults & Persons with Brain Injuries (APP Prescribers Additional X-Waiver 16 Hours Training)

Thursday, Apr 15, 2021
Online via Zoom

Register

Screening, Assessment, and Treatment Initiation for SUDs (APP Prescribers Additional X-Waiver 16 Hours Training)

Saturday, Apr 17, 2021
Online via Zoom

Register

Medical Considerations for People with SUD, Overdose Education, and Naloxone Rescue Kits (APP Prescribers Additional X-Waiver 16

Thursday, Apr 22, 2021
Online via Zoom

Register

X-Waiver Training

Friday, Apr 23, 2021
Online via Zoom

Register

Medications for OUD and Addressing Polysubstance Use (APP Prescribers Additional X-Waiver 16 Hours Training)

Saturday, Apr 24, 2021
Online via Zoom

Register

A How-To Guide for Integrating OUD Treatment into Your Practice (APP Prescribers Additional X-Waiver 16 Hours Training)

Saturday, Apr 24, 2021
Online via Zoom

Register

OBAT TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for OBAT TTA is provided by:

Commonwealth of Massachusetts Department of Public Health
Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation

© 2021 Boston Medical Center. All rights reserved. Site by Signal.